Observational studyJournal of cachexia, sarcopenia and muscle2026
Denosumab Versus Zoledronic Acid for Muscle Strength and Physical Performance in Postmenopausal Osteoporosis: A 3-Year Prospective Study.
Xiangwen Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.